The news: The FDA called out drugmaker AbbVie for making misleading claims in a TV ad about how quickly the migraine medication Ubrelvy eliminates pain.
- Ubrelvy is manufactured by Allergan, a company acquired by AbbVie in 2020.
- For context, the FDA regulates prescription drug advertising on TV and other media channels.